China Pharma Outsourcing Market by 2020

Today, all world major pharma companies have identified a number of key emerging markets to focus on. Among them, China is commonly considered one of the most attractive markets. The fast rising pharmaceutical market, coupled with other unique features, such as a large pool of talents who possess the desired technical skills and the required service capabilities, has made China one of the most favored destinations around the world for pharma outsourcing. Thus far a large number of pharma-related companies from all over the world have conducted a variety of outsourcing activities in the country.

The last several years have witnessed the fast development of the Chinese pharma outsourcing service industry in all aspects. The industry has now possessed a complete structure with all service elements. The booming Chinese pharma outsourcing service market has not only fostered the emergence of a large number of local professional service providers but also attracted the entrance of an almost equally large number of experienced multinational service companies. The fast growth of this Chinese market has thus created enormous opportunities to a variety of organizations around the world, including outsourcing companies, service providers and venture capital investors. Whether this Chinese market will still have the same growth potential in the foreseeable future as it was in the past has thus become the most demanded subject among a larger number of organizations around the world.

The report, “China Pharma Outsourcing Market by 2020”, published by JZMed, Inc, a world renowned market research firm specialized in pharmaceutical outsourcing industry, is designed to provide in-depth analysis and detail answers to these subjects. It has conducted so far the most complete and comprehensive investigations about the development pattern of this Chinese industry, the service capability of Chinese CROs and CMOs, and the current market size of each service sector as well as the entire industry. It has thus displayed a new, complete picture of the Chinese pharma outsourcing service industry at present time. In addition, with an in-depth analysis on a variety of China outsourcing activities of a large number of multinational companies, the report also revealed the latest, most popular outsourcing models in China. More importantly, the report also examined in depth both the drivers and resistors of the future growth of this Chinese market. It has thus provided a clear insight about the future growth potentials and development patterns of this Chinese market.

The report is a must-read book to all global pharmaceutical, biotechnology, financial investment and outsourcing service companies that are interested to have a best position in the dynamically growing Chinese pharmaceutical outsourcing service market.

Main Features of the Report

• The report examined in depth the current market size, industry structural composition, and service capability in each sector of the entire Chinese pharma outsourcing service industry. It thus presents a clear and complete picture of the current development state of this China industry.
• The report also examined in depth the latest China outsourcing activities of a large number of multinational companies, both major pharmas and biotechs. It illustrated in detail of how these multinational companies from all over the world, large, small, and even startup, have been practicing outsourcing in China. It has thus revealed the latest, most popular outsourcing models currently prevailing in the Chinese market.
• Moreover, based on the analysis on the current global operating strategies of multinational pharma and biotech companies, the report also rationalized how these companies will likely develop their China outsourcing strategies in both R&D and manufacturing and their impacts on the growth of this Chinese market in the foreseeable future.
• Through investigating the current presences and services offered in China by multinational CROs and CMOs, the report also revealed how these experienced multinational service companies have been competing within this Chinese market, both with each other and with local Chinese service providers, and the impacts of their presence on the future development path of this Chinese industry.
• The report further analyzed in depth all drivers and resistors for future growth of this Chinese market. Based on these analyses, it quantitatively depicted a clear picture of future growth of this Chinese market.
• By comparing it head-to-head with the Indian pharma outsourcing service market, the report also studied this Chinese industry in the competitive landscape of the global pharma outsourcing industry. It has thus revealed the current relative competence of this Chinese industry within the global pharma outsourcing arena.
• The report contains the most complete, up-to-date market research data about the market values of all service sectors of the Chinese pharma outsourcing service industry. It thus helps both the service providers and venture capital investors as well as the pharma outsourcing companies best gauge the future growth potentials of this Chinese market.

Your Questions Are Answered

The report has addressed in detail each of the following questions:

• What is the current market size of the China pharma outsourcing service industry? What is the market size of each service sector? Where does China currently stand in the world pharma outsourcing service market?
• What is the best outsourcing model in China at present? Who are in China? What outsourcing activities do most drug companies have in China?
• What is the current structure of each service sector of this Chinese industry? What is the current service capability of each sector? What are current issues the industry needs to resolve?
• Who are the best players at present in this Chinese industry? What can they do? Are there any experienced multinational service providers in China? What service do they currently offer in China? What future strategies will they likely adopt in order to better position them in this competitive Chinese market?
• What are the future growth drivers and resistors of this Chinese market? Which service sector has been growing fastest so far? Which sector will have most future growth potential?
• What will the Chinese industry look like five to seven years from now? What about the possible market size by then? How to compare it with its global competitors? How will the service capability of this Chinese industry develop in the future?
• How will global pharma outsourcing service market develop in the next five to seven years? What roles will this Chinese industry play and where will it likely stand in the global market by then?